Decreased expression of ADAMTS-1 in human breast tumors stimulates migration and invasion

Molecular Cancer

Volumn 12, Issue 1, 2013, Pages

  Freitas, Vanessa M ^a   do Amaral, Jônatas Bussador ^a   Silva, Thaiomara A ^a   Santos, Emerson S ^a   Mangone, Flávia R ^a   Pinheiro, João de Jesus ^a,b   Jaeger, Ruy G ^a   Nagai, Maria A ^a   Machado Santelli, Gláucia Maria ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b FEDERAL UNIVERSITY OF PARÁ   (Brazil)

Author keywords

ADAMTS 1; Breast cancer; Invasion; Migration; VEGF

Indexed keywords

ADAMTS1 PROTEIN; BLOCKING ANTIBODY; EPIDERMAL GROWTH FACTOR RECEPTOR; ESTROGEN; MESSENGER RNA; PROGESTERONE; VASCULOTROPIN;

ADULT; ARTICLE; BREAST TUMOR; CANCER INVASION; CELL MIGRATION; CONTROLLED STUDY; HUMAN; HUMAN CELL; IMMUNOBLOTTING; IMMUNOCHEMISTRY; IN VITRO STUDY; PROTEIN DEPLETION; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; REGULATORY MECHANISM; TUMOR CELL LINE;

ADAM PROTEINS; ADULT; AGED; AGED, 80 AND OVER; BREAST NEOPLASMS; CARCINOMA, DUCTAL, BREAST; CELL MOVEMENT; CELL SURFACE EXTENSIONS; FEMALE; GENE EXPRESSION; GENE KNOCKDOWN TECHNIQUES; HUMANS; LYMPHATIC METASTASIS; MCF-7 CELLS; MIDDLE AGED; NEOPLASM INVASIVENESS; RECEPTOR, ERBB-2; RECEPTORS, ESTROGEN; RECEPTORS, PROGESTERONE; RNA, SMALL INTERFERING; TIME-LAPSE IMAGING; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR-2; YOUNG ADULT;

EID: 84871819207     PISSN: None     EISSN: 14764598     Source Type: Journal    
DOI: 10.1186/1476-4598-12-2     Document Type: Article

References (38)

1. Comoglio PM, Trusolino L. Cancer: the matrix is now in control. Nat Med 2005, 11:1156-1159. 10.1038/nm1105-1156, 16270068.
2. Kleinman HK, Philp D, Hoffman MP. Role of the extracellular matrix in morphogenesis. Curr Opin Biotechnol 2003, 14:526-532. 10.1016/j.copbio.2003.08.002, 14580584.
3. Rocks N, Paulissen G, El Hour M, Quesada F, Crahay C, Gueders M, Foidart JM, Noel A, Cataldo D. Emerging roles of ADAM and ADAMTS metalloproteinases in cancer. Biochimie 2008, 90:369-379. 10.1016/j.biochi.2007.08.008, 17920749.
4. Pantel K, Brakenhoff RH. Dissecting the metastatic cascade. Nat Rev Cancer 2004, 4:448-456. 10.1038/nrc1370, 15170447.
5. Brown HM, Dunning KR, Robker RL, Pritchard M, Russell DL. Requirement for ADAMTS-1 in extracellular matrix remodeling during ovarian folliculogenesis and lymphangiogenesis. Dev Biol 2006, 300:699-709. 10.1016/j.ydbio.2006.10.012, 17097630.
6. Iruela-Arispe ML, Carpizo D, Luque A. ADAMTS1: a matrix metalloprotease with angioinhibitory properties. Ann N Y Acad Sci 2003, 995:183-190. 10.1111/j.1749-6632.2003.tb03221.x, 12814950.
7. Luque A, Carpizo DR, Iruela-Arispe ML. ADAMTS1/METH1 inhibits endothelial cell proliferation by direct binding and sequestration of VEGF165. J Biol Chem 2003, 278:23656-23665. 10.1074/jbc.M212964200, 12716911.
8. Ng YH, Zhu H, Pallen CJ, Leung PC, MacCalman CD. Differential effects of interleukin-1beta and transforming growth factor-beta1 on the expression of the inflammation-associated protein, ADAMTS-1, in human decidual stromal cells in vitro. Hum Reprod 2006, 21:1990-1999. 10.1093/humrep/del108, 16675485.
9. Kuno K, Okada Y, Kawashima H, Nakamura H, Miyasaka M, Ohno H, Matsushima K. ADAMTS-1 cleaves a cartilage proteoglycan, aggrecan. FEBS Lett 2000, 478:241-245. 10.1016/S0014-5793(00)01854-8, 10930576.
10. Rocks N, Paulissen G, Quesada-Calvo F, Munaut C, Gonzalez ML, Gueders M, Hacha J, Gilles C, Foidart JM, Noel A, Cataldo DD. ADAMTS-1 metalloproteinase promotes tumor development through the induction of a stromal reaction in vivo. Cancer Res 2008, 68:9541-9550. 10.1158/0008-5472.CAN-08-0548, 19010931.
11. Masui T, Hosotani R, Tsuji S, Miyamoto Y, Yasuda S, Ida J, Nakajima S, Kawaguchi M, Kobayashi H, Koizumi M. Expression of METH-1 and METH-2 in pancreatic cancer. Clin Cancer Res 2001, 7:3437-3443.
12. Porter S, Scott SD, Sassoon EM, Williams MR, Jones JL, Girling AC, Ball RY, Edwards DR. Dysregulated expression of adamalysin-thrombospondin genes in human breast carcinoma. Clin Cancer Res 2004, 10:2429-2440. 10.1158/1078-0432.CCR-0398-3, 15073121.
13. Chen CH, Lai JM, Chou TY, Chen CY, Su LJ, Lee YC, Cheng TS, Hong YR, Chou CK, Whang-Peng J. VEGFA upregulates FLJ10540 and modulates migration and invasion of lung cancer via PI3K/AKT pathway. PLoS One 2009, 4:e5052. 10.1371/journal.pone.0005052, 2659802, 19337377.
14. Green CE, Liu T, Montel V, Hsiao G, Lester RD, Subramaniam S, Gonias SL, Klemke RL. Chemoattractant signaling between tumor cells and macrophages regulates cancer cell migration, metastasis and neovascularization. PLoS One 2009, 4:e6713. 10.1371/journal.pone.0006713, 2725301, 19696929.
15. Lucas JT, Salimath BP, Slomiany MG, Rosenzweig SA. Regulation of invasive behavior by vascular endothelial growth factor is HEF1-dependent. Oncogene 2010, 29:4449-4459. 10.1038/onc.2010.185, 2921319, 20498643.
16. Oommen S, Gupta SK, Vlahakis NE. Vascular endothelial growth factor A (VEGF-A) induces endothelial and cancer cell migration through direct binding to integrin {alpha}9{beta}1: identification of a specific {alpha}9{beta}1 binding site. J Biol Chem 2011, 286:1083-1092. 10.1074/jbc.M110.175158, 3020715, 21071450.
17. Prager GW, Lackner EM, Krauth MT, Unseld M, Poettler M, Laffer S, Cerny-Reiterer S, Lamm W, Kornek GV, Binder BR. Targeting of VEGF-dependent transendothelial migration of cancer cells by bevacizumab. Mol Oncol 2010, 4:150-160. 10.1016/j.molonc.2010.01.002, 20106729.
18. Zhu C, Xiong Z, Chen X, Lu Z, Zhou G, Wang D, Bao J, Hu X. Soluble vascular endothelial growth factor (VEGF) receptor-1 inhibits migration of human monocytic THP-1 cells in response to VEGF. Inflamm Res 2011, 60:769-774. 10.1007/s00011-011-0332-7, 21487788.
19. Kuno K, Kanada N, Nakashima E, Fujiki F, Ichimura F, Matsushima K. Molecular cloning of a gene encoding a new type of metalloproteinase-disintegrin family protein with thrombospondin motifs as an inflammation associated gene. J Biol Chem 1997, 272:556-562. 10.1074/jbc.272.1.556, 8995297.
20. Robker RL, Russell DL, Espey LL, Lydon JP, O'Malley BW, Richards JS. Progesterone-regulated genes in the ovulation process: ADAMTS-1 and cathepsin L proteases. Proc Natl Acad Sci U S A 2000, 97:4689-4694. 10.1073/pnas.080073497, 18294, 10781075.
21. Shindo T, Kurihara H, Kuno K, Yokoyama H, Wada T, Kurihara Y, Imai T, Wang Y, Ogata M, Nishimatsu H. ADAMTS-1: a metalloproteinase-disintegrin essential for normal growth, fertility, and organ morphology and function. J Clin Invest 2000, 105:1345-1352. 10.1172/JCI8635, 315464, 10811842.
22. Lu X, Wang Q, Hu G, Van Poznak C, Fleisher M, Reiss M, Massague J, Kang Y. ADAMTS1 and MMP1 proteolytically engage EGF-like ligands in an osteolytic signaling cascade for bone metastasis. Genes Dev 2009, 23:1882-1894. 10.1101/gad.1824809, 2725946, 19608765.
23. Liu YJ, Xu Y, Yu Q. Full-length ADAMTS-1 and the ADAMTS-1 fragments display pro- and antimetastatic activity, respectively. Oncogene 2006, 25:2452-2467. 10.1038/sj.onc.1209287, 2759703, 16314835.
24. Rehn AP, Birch MA, Karlstrom E, Wendel M, Lind T. ADAMTS-1 increases the three-dimensional growth of osteoblasts through type I collagen processing. Bone 2007, 41:231-238. 10.1016/j.bone.2007.04.187, 17560840.
25. Cabodi S, Taverna D. Interfering with inflammation: a new strategy to block breast cancer self-renewal and progression?. Breast Cancer Res 2010, 12:305. 10.1186/bcr2563, 2879570, 20459595.
26. Entschladen F, Drell TL, Lang K, Joseph J, Zaenker KS. Tumour-cell migration, invasion, and metastasis: navigation by neurotransmitters. Lancet Oncol 2004, 5:254-258. 10.1016/S1470-2045(04)01431-7, 15050959.
27. Kraljevic Pavelic S, Sedic M, Bosnjak H, Spaventi S, Pavelic K. Metastasis: new perspectives on an old problem. Mol Cancer 2011, 10:22. 10.1186/1476-4598-10-22, 3052211, 21342498.
28. Hayot C, Debeir O, Van Ham P, Van Damme M, Kiss R, Decaestecker C. Characterization of the activities of actin-affecting drugs on tumor cell migration. Toxicol Appl Pharmacol 2006, 211:30-40. 10.1016/j.taap.2005.06.006, 16005926.
29. Krampert M, Kuenzle S, Thai SN, Lee N, Iruela-Arispe ML, Werner S. ADAMTS1 proteinase is up-regulated in wounded skin and regulates migration of fibroblasts and endothelial cells. J Biol Chem 2005, 280:23844-23852. 10.1074/jbc.M412212200, 15843381.
30. Artym VV, Zhang Y, Seillier-Moiseiwitsch F, Yamada KM, Mueller SC. Dynamic interactions of cortactin and membrane type 1 matrix metalloproteinase at invadopodia: defining the stages of invadopodia formation and function. Cancer Res 2006, 66:3034-3043. 10.1158/0008-5472.CAN-05-2177, 16540652.
31. Bowden ET, Onikoyi E, Slack R, Myoui A, Yoneda T, Yamada KM, Mueller SC. Co-localization of cortactin and phosphotyrosine identifies active invadopodia in human breast cancer cells. Exp Cell Res 2006, 312:1240-1253. 10.1016/j.yexcr.2005.12.012, 16442522.
32. Kelly T, Yan Y, Osborne RL, Athota AB, Rozypal TL, Colclasure JC, Chu WS. Proteolysis of extracellular matrix by invadopodia facilitates human breast cancer cell invasion and is mediated by matrix metalloproteinases. Clin Exp Metastasis 1998, 16:501-512. 10.1023/A:1006538200886, 9872598.
33. Mader CC, Oser M, Magalhaes MA, Bravo-Cordero JJ, Condeelis J, Koleske AJ, Gil-Henn H. An EGFR-Src-Arg-cortactin pathway mediates functional maturation of invadopodia and breast cancer cell invasion. Cancer Res 2011, 71:1730-1741. 10.1158/0008-5472.CAN-10-1432, 3057139, 21257711.
34. Nascimento CF, Gama-De-Souza LN, Freitas VM, Jaeger RG. Role of MMP9 on invadopodia formation in cells from adenoid cystic carcinoma. Study by laser scanning confocal microscopy. Microsc Res Tech 2010, 73:99-108.
35. Buccione R, Orth JD, McNiven MA. Foot and mouth: podosomes, invadopodia and circular dorsal ruffles. Nat Rev Mol Cell Biol 2004, 5:647-657. 10.1038/nrm1436, 15366708.
36. Linder S. The matrix corroded: podosomes and invadopodia in extracellular matrix degradation. Trends Cell Biol 2007, 17:107-117. 10.1016/j.tcb.2007.01.002, 17275303.
37. Stylli SS, Kaye AH, Lock P. Invadopodia: at the cutting edge of tumour invasion. J Clin Neurosci 2008, 15:725-737. 10.1016/j.jocn.2008.03.003, 18468901.
38. Chomczynski P, Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 1987, 162:156-159.